Nova Research Laboratories is a biotechnology and healthcare startup proclaiming themselves as "The ion channel experts." With a legacy dating back to the 1980s, the NOVA team has been deeply entrenched in ion channel research, contributing significant data for regulatory guidelines. Their notable involvements include conducting the hERG screening for the original ILSI/HESI safety study, laying the groundwork for the current S7B guidelines, and providing ion channel screening for the FDA in support of the new CiPA safety assessment guidelines. Additionally, NOVA has collaborated with numerous companies and government agencies, assisting in the de-risking of compounds.
There is no investment information
No recent news or press coverage available for Nova Research Laboratories.